Intelligent IRT Design Process For COVID-19 Trials Accelerates Digital Enablement At Sites

Cenduit IRT study design teams took-on the challenges pressing biopharmaceutical industry sponsors as they worked to digitally enable sites and speed time to first-patient-in for COVID-19 therapeutic and vaccine trials.

What resulted included new intelligent design standards that launched seventeen COVID-19 studies rapidly, setting a new bar for accelerating study design by building flexibility into study design standardization.